Centogene N.V. Gains 33.9%
Centogene N.V. (CNTG:NASDAQ) shot up at $1.58, representing a gain of 33.9%. On Wed, Jun 28, 2023, CNTG:NASDAQ touched a New 2-Week High of $1.58. The stock appeared on our News Catalysts scanner on Tue, Jun 27, 2023 at 07:55 AM in the 'PATNERSHIP' category. From Wed, Jun 14, 2023, the stock recorded 55.56% Up Days and 50.00% Green Days
The stock spiked on Wed, Jun 28, 2023 at $1.98 with a volume of 31M+.
About Centogene N.V. (CNTG:NASDAQ)
Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It's pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 80%
- Minerva Neurosciences, Inc. (NERV:NASDAQ), 69.27%
- Signature Bank (SBNY:NASDAQ), 61.79%
- Knightscope Inc. (KSCP:NASDAQ), 52.15%
- Joby Aviation Inc. (JOBY:NYSE), 40.22%
- Kaleyra Inc. (KLR:NYSE), 39.38%
- Centogene N.V. (CNTG:NASDAQ), 33.9%
- Evelo Biosciences, Inc. (EVLO:NASDAQ), 33.86%
- Trio Petroleum Corp. (TPET:NYSEMKT), 33.64%
- AgeX Therapeutics, Inc. (AGE:NYSEMKT), 32.27%